רקומבינאט IU 1000
Country: Israel
Language: Hebrew
Source: Ministry of Health
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
COAGULATION FACTOR VIII RECOMBINANT 1000 IU/VIAL
Available from:
TEVA MEDICAL MARKETING LTD.
ATC code:
B02BD02
Pharmaceutical form:
POWDER FOR SOLUTION FOR INJECTION
Administration route:
I.V
Manufactured by:
BAXTER S.A., BELGIUM
Therapeutic group:
COAGULATION FACTOR VIII
Therapeutic indications:
The use of Recombinate is indicated in the treatment and prophylaxis of bleeding in patients with haemophilia A (congenital factor VIII deficiency). Recombinate is also indicated in the perioperative management of patients with haemophilia A. Recombinate is appropriate for use in children of all ages including the newborn. (Safety and efficacy studies have been performed in both previously treated and previously untreated children). The product in not suitable for the treatment of von Willebrand's disease.
Authorization date:
2010-07-01
